Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study

Published: 29 September 2025| Version 1 | DOI: 10.17632/n925sv5cr3.1
Contributors:
,
,
, Michael Stephens

Description

Supplementary materials for "Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study"

Files

Institutions

  • Harvard Medical School
  • Massachusetts General Hospital

Categories

Dermatological Disease, Graft-versus-Host Disease

Licence